title: MIR21 is differentially expressed in the lymphoid tissue and modulated by stromal signalling in chronic lymphocytic leukaemia.
authors: Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
authors: Olga V
authors: OV
authors: Danilova
authors: Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
authors: Cody
authors: C
authors: Paiva
authors: Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
authors: Prabhjot
authors: P
authors: Kaur
authors: Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
authors: Ahsan
authors: A
authors: Kamal
authors: Center for Translational Medicine at Van Andel Research Institute, Grand Rapids, MI, USA.
authors: Lorenzo F
authors: LF
authors: Sempere
authors: Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. danilov@ohsu.edu.
authors: Alexey V
authors: AV
authors: Danilov
mesh_terms: D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics* / Q000378:metabolism*; D008221:Lymphoid Tissue / Q000378:metabolism* / Q000473:pathology; D035683:MicroRNAs / Q000235:genetics*; D015398:Signal Transduction; D017154:Stromal Cells / Q000378:metabolism*
chemical_list: C524940:MIRN21 microRNA, human; D035683:MicroRNAs
keywords: B-cell receptor; NF-kappaB; chronic lymphocytic leukaemia; microRNA